Who is sponsoring NCT03039322?

NCT03039322 is sponsored by Ain Shams University.

What drugs are being tested in NCT03039322?

Interventions in NCT03039322: Serum Golgi Protein 73.

What condition does NCT03039322 study?

NCT03039322 studies Screening for Hepatocellular Carcinoma.

Is NCT03039322 still recruiting?

NCT03039322 is currently completed. Last updated 1 February 2017.

Last reviewed 2017-02-01 · How we verify

NCT03039322

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Golgi Protein for HCC Diagnosis

Completed Last updated 1 February 2017

What this trial tests

trial testing Serum Golgi Protein 73 in Screening for Hepatocellular Carcinoma in 90 participants. Completed in 30 December 2015.

Timeline

22 December 2014

Primary endpoint
30 December 2015

30 December 2015

Quick facts

Lead sponsor	Ain Shams University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	90
Start date	22 December 2014
Primary completion	30 December 2015
Estimated completion	30 December 2015

Drugs / interventions tested

Serum Golgi Protein 73

Conditions studied

Screening for Hepatocellular Carcinoma — all drugs for Screening for Hepatocellular Carcinoma →

Sponsor

Ain Shams University

Who can join

Adults 18 to 75, any sex, with Screening for Hepatocellular Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This case-control study was conducted on 90 patients who were equally divided into two groups. Group 1 included 45 patients with HCV-related chronic liver disease without clinical or radiological evidence of HCC (control group), and Group 2 included 45 patients diagnosed to have HCC by Triphasic abdominal CT (patient group). Serum AFP and GP73 were measured using ELISA technique

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03039322 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 1 February 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03039322.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing